Biodesix (BDSX) EBIAT: 2019-2025
Historic EBIAT for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$8.7 million.
- Biodesix's EBIAT rose 15.03% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.5 million, marking a year-over-year increase of 9.77%. This contributed to the annual value of -$42.9 million for FY2024, which is 17.67% up from last year.
- According to the latest figures from Q3 2025, Biodesix's EBIAT is -$8.7 million, which was up 24.00% from -$11.5 million recorded in Q2 2025.
- In the past 5 years, Biodesix's EBIAT ranged from a high of -$7.0 million in Q1 2021 and a low of -$20.3 million during Q4 2022.
- Moreover, its 3-year median value for EBIAT was -$10.9 million (2023), whereas its average is -$11.5 million.
- Per our database at Business Quant, Biodesix's EBIAT plummeted by 193.01% in 2021 and then surged by 55.06% in 2023.
- Quarterly analysis of 5 years shows Biodesix's EBIAT stood at -$13.3 million in 2021, then slumped by 53.12% to -$20.3 million in 2022, then soared by 55.06% to -$9.1 million in 2023, then grew by 9.72% to -$8.3 million in 2024, then rose by 15.03% to -$8.7 million in 2025.
- Its last three reported values are -$8.7 million in Q3 2025, -$11.5 million for Q2 2025, and -$11.1 million during Q1 2025.